Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIncanthera Share Price (INC.PL)

Share Price Information for Incanthera (INC.PL)

Share Price is delayed by 15 minutes
Get Live Data
1.975    0.575 (41.07%)
Bid:
1.75
Ask:
2.20
Spread: 0.45 (25.714%)
Market Cap: £2.72m
INC.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Incanthera Share Chart

Incanthera Share Price
Price 1.975 Open 1.55
Bid 1.75 High 2.15
Ask 2.20 Low 1.55
Change 0.575 (41.07%) Close 1.40
Volume 702,155
Currency GBX
Issue Country GB
Shares in Issue 137.94m
Market Cap £2.72m
PE Ratio 0.00
EPS 0.00
Year High 6.25
Year High Date 11-Aug-2025
Year Low 0.75
Year Low Date 02-Apr-2026
Dividend 0.00
Yield 0.00%
# Trades 18
Vol. Sold 143,655
Sold Value £2.65k
Vol. Bought 528,500
Bought Value £10.40k
Market Size 0
What if I invested £1,000 in Incanthera?
£ 1,462.96 (+46.30%)
1 month ago
£ 790.00 (-21.00%)
3 months ago
£ 564.29 (-43.57%)
6 months ago
£ 395.00 (-60.50%)
1 year ago
Add INC.PL to WatchlistAdd INC.PL to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Incanthera Plc

Incanthera Plc is listed on the Aquis Stock Exchange trading with ticker code INC.PL. It has a market capitalisation of £2.72m, with approximately 137.94m shares in issue. Over the last year, Incanthera share price has been traded in a range of 5.50, hitting a high of 6.25, and a low of 0.75.

Incanthera is a British biopharmaceutical company headquartered in Manchester, specialising in the development of targeted cancer therapies. Established in 2010, the company focuses on innovative treatments designed to improve the efficacy and safety of cancer care. Incanthera's lead programme, Sol, is a topical formulation aimed at treating solar keratosis and preventing skin cancer. Committed to advancing oncology research, the company leverages cutting-edge science and strategic collaborations to bring novel therapies to market. Incanthera's mission is to enhance patient outcomes and contribute to the fight against cancer through pioneering medical solutions.

Some Videos You Might Like

Sovereign Metals Signs Mits...


 

Wishbone Gold announce 2025...


What's Hot 8th April 2026


Recent Share Trades for Incanthera (INC.PL)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
04-Jun-2612:59:051.850150,000Sell*1.752.30925.05O Ordinary
04-Jun-2612:59:012.21550,000Buy*1.752.301,108O Ordinary
04-Jun-2612:51:162.244950,000Buy*1.752.301,122O Ordinary
04-Jun-2612:51:061.8550,000Sell*1.752.30925.00O Ordinary
04-Jun-2610:53:122.24492,274Buy*1.752.3051.05O Ordinary
04-Jun-2610:36:162.24498,742Buy*1.752.30196.25O Ordinary
04-Jun-2610:13:512.24496,372Buy*1.752.30143.05O Ordinary
04-Jun-2610:13:441.832643,654Sell*1.752.30800.00O Ordinary
04-Jun-2609:58:312.239950,000Buy*2.002.301,120O Ordinary
04-Jun-2609:51:272.1530,000Unknown*2.002.30645.00O Ordinary
  • This chat board is for this share's listing on the Aquis Stock Exchange.